Matches in SemOpenAlex for { <https://semopenalex.org/work/W4310251558> ?p ?o ?g. }
- W4310251558 endingPage "107" @default.
- W4310251558 startingPage "95" @default.
- W4310251558 abstract "Introduction. For the last decade, nanotechnology has been studied extensively in the pharmaceutical field. Among all the nanotechnology formulation areas, nanostructured lipid carrier is enormously researched by formulation scientists as it is one of the focused areas of lipid carrier for the effective formulation. Materials and methods. The nanostructured lipid carrier (NLC) consists of solid lipid, liquid lipid & surfactant for fabrication of formulation. Methods such as high energy methods, low energy methods and organic solvent-based methods are used for the preparation of NLC. As per literature study the High pressure homogenization is the most efficient method for fabrication of formulation. Results and discussion. This carrier system has significant advantages such as high drug entrapment, improved bioavailability, stability during storage, and targeting the site with a better-controlled release making it a prominent area for the formulator to emphasize on it. Although many drugs are formulated with a nanostructured lipid carrier, it is a concern for researchers to find out the effectiveness of formulation by studying the process parameter and safety. Conclusion. The present review was focused to study the impact of various parameters such as Lipid, surfactant, homogenization rate, preservative, Crystallinity, and surface charge on the formulation. The study also extended towards toxicity and biocompatibility, topical targeting & cancer treatment of the Nanostructured lipid carrier." @default.
- W4310251558 created "2022-11-30" @default.
- W4310251558 creator A5028518634 @default.
- W4310251558 creator A5040711958 @default.
- W4310251558 creator A5081496795 @default.
- W4310251558 date "2022-11-25" @default.
- W4310251558 modified "2023-09-26" @default.
- W4310251558 title "Impact of Parameter on Nanostructured Lipid Carrier Formulation and Approach of the Carrier for Cancer Treatment: a Brief Study" @default.
- W4310251558 cites W1579046626 @default.
- W4310251558 cites W1606639417 @default.
- W4310251558 cites W1687377681 @default.
- W4310251558 cites W1715711087 @default.
- W4310251558 cites W1734250133 @default.
- W4310251558 cites W1740079658 @default.
- W4310251558 cites W1861336709 @default.
- W4310251558 cites W1972144921 @default.
- W4310251558 cites W1972856288 @default.
- W4310251558 cites W1974050571 @default.
- W4310251558 cites W1974471610 @default.
- W4310251558 cites W1974589872 @default.
- W4310251558 cites W1978647910 @default.
- W4310251558 cites W1986012609 @default.
- W4310251558 cites W1987732178 @default.
- W4310251558 cites W1991885178 @default.
- W4310251558 cites W1996165533 @default.
- W4310251558 cites W1998654818 @default.
- W4310251558 cites W1999761664 @default.
- W4310251558 cites W2005395252 @default.
- W4310251558 cites W2007327214 @default.
- W4310251558 cites W2013630484 @default.
- W4310251558 cites W2015655960 @default.
- W4310251558 cites W2022879500 @default.
- W4310251558 cites W2024112810 @default.
- W4310251558 cites W2025722135 @default.
- W4310251558 cites W2035381945 @default.
- W4310251558 cites W2040479156 @default.
- W4310251558 cites W2042789685 @default.
- W4310251558 cites W2047465751 @default.
- W4310251558 cites W2049626483 @default.
- W4310251558 cites W2051959623 @default.
- W4310251558 cites W2060969120 @default.
- W4310251558 cites W2061908567 @default.
- W4310251558 cites W2063742687 @default.
- W4310251558 cites W2069206946 @default.
- W4310251558 cites W2078768792 @default.
- W4310251558 cites W2079141026 @default.
- W4310251558 cites W2085146016 @default.
- W4310251558 cites W2087020662 @default.
- W4310251558 cites W2092719511 @default.
- W4310251558 cites W2133493020 @default.
- W4310251558 cites W2147575825 @default.
- W4310251558 cites W2151291833 @default.
- W4310251558 cites W2162933728 @default.
- W4310251558 cites W2174258218 @default.
- W4310251558 cites W2265120954 @default.
- W4310251558 cites W2288622129 @default.
- W4310251558 cites W2497456934 @default.
- W4310251558 cites W2523136354 @default.
- W4310251558 cites W2605952271 @default.
- W4310251558 cites W2795520787 @default.
- W4310251558 cites W2800752654 @default.
- W4310251558 cites W2892585496 @default.
- W4310251558 cites W2896087117 @default.
- W4310251558 cites W2898146268 @default.
- W4310251558 cites W2912781962 @default.
- W4310251558 cites W2929104561 @default.
- W4310251558 cites W2952748902 @default.
- W4310251558 cites W2957834687 @default.
- W4310251558 cites W2965071598 @default.
- W4310251558 cites W3008004285 @default.
- W4310251558 cites W3012817514 @default.
- W4310251558 cites W3023464520 @default.
- W4310251558 cites W3029623884 @default.
- W4310251558 cites W3093137796 @default.
- W4310251558 cites W3161949483 @default.
- W4310251558 cites W3163904000 @default.
- W4310251558 cites W3170578903 @default.
- W4310251558 cites W3199437020 @default.
- W4310251558 cites W37840549 @default.
- W4310251558 cites W4220872365 @default.
- W4310251558 cites W4226012283 @default.
- W4310251558 cites W4229646173 @default.
- W4310251558 doi "https://doi.org/10.33380/2305-2066-2022-11-4-95-107" @default.
- W4310251558 hasPublicationYear "2022" @default.
- W4310251558 type Work @default.
- W4310251558 citedByCount "0" @default.
- W4310251558 crossrefType "journal-article" @default.
- W4310251558 hasAuthorship W4310251558A5028518634 @default.
- W4310251558 hasAuthorship W4310251558A5040711958 @default.
- W4310251558 hasAuthorship W4310251558A5081496795 @default.
- W4310251558 hasBestOaLocation W43102515581 @default.
- W4310251558 hasConcept C127413603 @default.
- W4310251558 hasConcept C130217890 @default.
- W4310251558 hasConcept C13245373 @default.
- W4310251558 hasConcept C155672457 @default.
- W4310251558 hasConcept C171250308 @default.
- W4310251558 hasConcept C18903297 @default.
- W4310251558 hasConcept C191897082 @default.